72 related articles for article (PubMed ID: 35775295)
21. Follow-up after abnormal cervical cancer screening in immigrants compared with Danish-born women - A nationwide register study.
Hertzum-Larsen R; Kjær SK; Frederiksen K; Thomsen LT
Prev Med; 2021 Dec; 153():106776. PubMed ID: 34450191
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of the prevalence of the human papilloma virus in Spanish and foreign women participating in a population screening programme in Castilla y León.
García-Villanueva S; Domínguez-Gil González M; Gayete Martínez J; Muñoz Bellido JL; Salas Valien JS; Echevarria Iturbe C; González Sagrado M; Jiménez Pérez JM; Curiel de Arcaute López A; Rojo Rello S; Eiros Bouza JM; Ortiz de Lejarazu Leonardo R
Enferm Infecc Microbiol Clin (Engl Ed); 2019 May; 37(5):314-318. PubMed ID: 31036251
[TBL] [Abstract][Full Text] [Related]
23. Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study.
Zhao Y; Bao H; Ma L; Song B; Di J; Wang L; Gao Y; Ren W; Wang S; Wang HJ; Wu J
BMC Med; 2021 Jul; 19(1):164. PubMed ID: 34261463
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
25. Activity level and process indicators of organised programmes for cervical cancer screening in Italy.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2006; 30(1 Suppl 3):27-40. PubMed ID: 16937844
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of diabetes across different immigrant groups in North-eastern Italy.
Fedeli U; Casotto V; Ferroni E; Saugo M; Targher G; Zoppini G
Nutr Metab Cardiovasc Dis; 2015 Oct; 25(10):924-30. PubMed ID: 26231618
[TBL] [Abstract][Full Text] [Related]
27. Organized primary human papillomavirus-based cervical screening: A randomized healthcare policy trial.
Elfström KM; Eklund C; Lamin H; Öhman D; Hortlund M; Elfgren K; Sundström K; Dillner J
PLoS Med; 2021 Aug; 18(8):e1003748. PubMed ID: 34424907
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
29. Screening for cervical cancer with the human papillomavirus test in an area of central Italy with no previous active cytological screening programme.
Confortini M; Giorgi Rossi P; Barbarino P; Passarelli AM; Orzella L; Tufi MC
J Med Screen; 2010; 17(2):79-86. PubMed ID: 20660436
[TBL] [Abstract][Full Text] [Related]
30. HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs.
Campari C; Fedato C; Petrelli A; Zorzi M; Cogo C; Caprioglio A; Gallo F; Giordano L; Domenighini S; Pasquale L; Prandi S; Zappa M; Giorgi Rossi P;
Infect Agent Cancer; 2015; 10():14. PubMed ID: 25969693
[TBL] [Abstract][Full Text] [Related]
31. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.
Kitchener HC; Almonte M; Gilham C; Dowie R; Stoykova B; Sargent A; Roberts C; Desai M; Peto J;
Health Technol Assess; 2009 Nov; 13(51):1-150, iii-iv. PubMed ID: 19891902
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of human papillomavirus infection in Eastern European and West African women immigrants in South Italy.
Tornesello ML; Cassese R; De Rosa N; Buonaguro L; Masucci A; Vallefuoco G; Palmieri S; Schiavone V; Piccoli R; Buonaguro FM
APMIS; 2011 Oct; 119(10):701-9. PubMed ID: 21917007
[TBL] [Abstract][Full Text] [Related]
33. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
Vahabi M; Lofters A
BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P
BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369
[TBL] [Abstract][Full Text] [Related]
35. [Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project].
Di Stefano F; Giorgi Rossi P; Carozzi F; Ronco G; Cacciani L; Vecchi S; Naldoni C; Segnan N;
Epidemiol Prev; 2017; 41(2):116-124. PubMed ID: 28627153
[TBL] [Abstract][Full Text] [Related]
36. Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study.
Yuill S; Egger S; Smith MA; Velentzis L; Saville M; Kliewer EV; Bateson D; Canfell K
J Med Screen; 2024 Mar; 31(1):35-45. PubMed ID: 37464811
[TBL] [Abstract][Full Text] [Related]
37. The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study.
Herweijer E; Feldman AL; Ploner A; Arnheim-Dahlström L; Uhnoo I; Netterlid E; Dillner J; Sparén P; Sundström K
PLoS One; 2015; 10(7):e0134185. PubMed ID: 26218492
[TBL] [Abstract][Full Text] [Related]
38. Disparities in cervical screening participation: a comparison of Russian, Somali and Kurdish immigrants with the general Finnish population.
Idehen EE; Koponen P; Härkänen T; Kangasniemi M; Pietilä AM; Korhonen T
Int J Equity Health; 2018 May; 17(1):56. PubMed ID: 29728104
[TBL] [Abstract][Full Text] [Related]
39. National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
Smith MA; Sherrah M; Sultana F; Castle PE; Arbyn M; Gertig D; Caruana M; Wrede CD; Saville M; Canfell K
BMJ; 2022 Mar; 376():e068582. PubMed ID: 35354610
[TBL] [Abstract][Full Text] [Related]
40. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]